NeuroCatch Inc., a brain health technology company based out of British Columbia, announced today it will open its United States headquarters in Greater Phoenix at the Phoenix Bioscience Core (PBC).

The company, an alumnus of the 2025 Arizona State University (ASU)/Mayo Clinic MedTech Accelerator, will support commercialization, manufacturing, sales, distribution, and clinical trials out of its new 1,000-square-foot office space. Operations began Oct. 1, with further scaling of operations planned into 2026.

“Phoenix has built one of the most dynamic healthcare and innovation ecosystems in the world, fueled with passionate people across all spectrums, and we are excited to become a part of it for the U.S. and global commercialization of our product,” CEO Derek Norsworthy said. “With NeuroCatch, we look forward to contributing our own breakthrough in brain health, helping expand the Valley’s impact outward to communities across the nation and around the world.”

This location represents NeuroCatch’s first major U.S. presence and will serve as a launchpad for commercialization throughout the U.S. Its primary technology, the NeuroCatch Platform, provides objective, rapid and non-invasive cognitive assessments using electroencephalography (EEG)-based brain vital signs. The company intends to hire approximately 10 new employees over the first three years.

Read Full Article